Evidence map›Paper›PMID 23017171›Full record

Trial reportPhotodermatology, photoimmunology & photomedicine2012

Evidence for a new paradigm for ultraviolet exposure: a universal schedule that is skin phototype independent.

Sharon A Miller, Sergio G Coelho, Scott W Miller, Yuji Yamaguchi, Vincent J Hearing, Janusz Z Beer

Abstract readClinical Trial
In one paragraph

Trial report in Photodermatology, photoimmunology & photomedicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sharon A MillerCenter for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD 20993, USA. sharona.miller@fda.hhs.gov
Sergio G Coelho
Scott W Miller
Yuji Yamaguchi
Vincent J Hearing
Janusz Z Beer

Funding

Biochemistry of Melanins and Photoprotection of the SkinZIABC010784 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HEARING, VINCENT J · 2009 to 2014
$2.2M
Intramural NIH HHS ZIA BC010784
6 · The paper itself

Abstract

backgroundThe Food and Drug Administration has published guidelines for manufacturer-recommended exposure schedules for ultraviolet (UV) tanning, intended to limit acute and delayed damage from UV exposure. These guidelines recommend that exposure schedules be adjusted for skin phototype. However, it has been shown that the dose necessary to produce tanning is similar for phototypes 2-4.

methodsWe observed tanning in phototypes 2 and 3 from repeated UV exposures over a 5-week period. Pigmentation was evaluated visually, instrumentally, and through Fontana-Masson staining of biopsies.

resultsThe resultant pigmentation was equal or greater in phototype 3 compared with phototype 2 - both visually and instrumentally - measured on day 31 of the exposure protocol. The amount of melanin measured in biopsies taken 24 h postexposure was also greater in phototype 3 compared with phototype 2.

conclusionPublished data on tanning in phototypes 4 and 5 support our findings that higher phototypes can develop pigmentation more efficiently than lower phototypes. Therefore, a universal exposure schedule (based on sensitivity of phototype 2) can be used for all phototypes that are expected to engage in indoor tanning. This approach will result in a reduction of the UV burden for skin phototypes 3 and above.

Indexed as

SunbathingAdultDose-Response Relationship, RadiationFemaleHumansMaleMiddle AgedSkinSkin PigmentationUltraviolet RaysUnited StatesUnited States Food and Drug Administration

Identifiers

PMID23017171
PMCPMC3462367

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.